These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia. Hurlemann R; Boy C; Meyer PT; Scherk H; Wagner M; Herzog H; Coenen HH; Vogeley K; Falkai P; Zilles K; Maier W; Bauer A Anat Embryol (Berl); 2005 Dec; 210(5-6):519-23. PubMed ID: 16187138 [TBL] [Abstract][Full Text] [Related]
23. Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET. Santhosh L; Estok KM; Vogel RS; Tamagnan GD; Baldwin RM; Mitsis EM; Macavoy MG; Staley JK; van Dyck CH Psychiatry Res; 2009 Sep; 173(3):212-7. PubMed ID: 19682865 [TBL] [Abstract][Full Text] [Related]
24. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461 [TBL] [Abstract][Full Text] [Related]
25. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. el Mansari M; Bouchard C; Blier P Neuropsychopharmacology; 1995 Oct; 13(2):117-27. PubMed ID: 8597523 [TBL] [Abstract][Full Text] [Related]
26. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230 [TBL] [Abstract][Full Text] [Related]
27. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Denys D; van der Wee N; Janssen J; De Geus F; Westenberg HG Biol Psychiatry; 2004 May; 55(10):1041-5. PubMed ID: 15121489 [TBL] [Abstract][Full Text] [Related]
28. Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study. Marner L; Frokjaer VG; Kalbitzer J; Lehel S; Madsen K; Baaré WF; Knudsen GM; Hasselbalch SG Neurobiol Aging; 2012 Mar; 33(3):479-87. PubMed ID: 20510480 [TBL] [Abstract][Full Text] [Related]
29. Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder. Vermeire S; Audenaert K; De Meester R; Vandermeulen E; Waelbers T; De Spiegeleer B; Eersels J; Dobbeleir A; Peremans K Psychiatry Res; 2012 Jan; 201(1):78-87. PubMed ID: 22285716 [TBL] [Abstract][Full Text] [Related]
30. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. Rosenberg DR; MacMaster FP; Keshavan MS; Fitzgerald KD; Stewart CM; Moore GJ J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1096-103. PubMed ID: 10986805 [TBL] [Abstract][Full Text] [Related]
31. 5-HT2A receptor density is decreased in the at-risk mental state. Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021 [TBL] [Abstract][Full Text] [Related]
32. Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652. Simpson HB; Lombardo I; Slifstein M; Huang HY; Hwang DR; Abi-Dargham A; Liebowitz MR; Laruelle M Biol Psychiatry; 2003 Dec; 54(12):1414-21. PubMed ID: 14675806 [TBL] [Abstract][Full Text] [Related]
33. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain. Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220 [TBL] [Abstract][Full Text] [Related]
34. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554 [TBL] [Abstract][Full Text] [Related]
35. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study. Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013 [TBL] [Abstract][Full Text] [Related]
36. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Aylward EH; Harris GJ; Hoehn-Saric R; Barta PE; Machlin SR; Pearlson GD Arch Gen Psychiatry; 1996 Jul; 53(7):577-84. PubMed ID: 8660124 [TBL] [Abstract][Full Text] [Related]